HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Angell, W. W. Articles by Grehl, T. M. Search for Related Content PubMed PubMed Citation Articles by Angell, W. W. Articles by Grehl, T. M.

The Journal of Thoracic and Cardiovascular Surgery, Vol 93, 815-822, Copyright © 1987 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Long-term follow-up of viable frozen aortic homografts. A viable homograft valve bank

WW Angell, JD Angell, JH Oury, JJ Lamberti and TM Grehl

There is currently a renewed interest in the use of both fresh and commercially available frozen homograft valves for children and young adults. This has prompted us to review a series of 32 patients who received frozen homograft valves for aortic replacement between 1973 and 1975. The cryogenic technique evolved to include the use of selected antibiotics and equilibrated dimethyl sulfoxide solution to freeze homografts at a rate of 1 degrees C per minute to liquid nitrogen temperatures of -196 degrees C. Histologic sections of experimental frozen valves explanted 6 months postoperatively revealed the presence of viable donor cells, and tissue culture demonstrated the reproductive capacity of cusp fibroblasts. Of the 32 frozen viable homografts implanted in this series, 23 were inserted as free-sewn aortic replacements and nine were premounted on stents before implantation in the aortic position. There were two operative deaths, and three valves failed as a result of the technical problems of mounting in one patient and surgical insertion of a free graft in two patients. Of the 22 patients who remained at long-term risk, 13% with free-sewn grafts and 57% with premounted valves underwent reoperation for valve failure. After 10 years of follow-up, 15 (68%) of these patients, 12 (80%) with free-sewn and three (43%) with premounted valves, are alive with their original valve in place. Actuarial analysis shows that 58% of the 32 valves implanted are functional at the beginning of the eleventh year. There have been six late deaths resulting in an overall actuarial patient survival rate of 79% at 10 years and 69% after 13 years. These clinical results are believed to add support to our current application of the frozen homograft in selected patients.

This article has been cited by other articles:

				M. E. Rendal Vazquez, T. D. Roman, M. G. Cuesta, C. Z. Botta, J. S. Ibanez, S. P. Diaz, and C. A. Nunez Viability and histologic structure of porcine valves after cryopreservation Ann. Thorac. Surg., January 1, 2004; 77(1): 186 - 190. [Abstract] [Full Text] [PDF]

				T. Walther, V. Falk, G. Langebartels, M. Kruger, U. Bernhardt, A. Diegeler, J. Gummert, R. Autschbach, and F. W. Mohr Prospectively Randomized Evaluation of Stentless Versus Conventional Biological Aortic Valves : Impact on Early Regression of Left Ventricular Hypertrophy Circulation, November 9, 1999; 100(90002): II-6 - 10. [Abstract] [Full Text] [PDF]

				P. Biberthaler, N. Mendler, U. Ettner, and H. Meisner Endothelial prostacyclin (PGI-2) production of human and porcine valve allografts related to ischemic history Eur. J. Cardiothorac. Surg., November 1, 1999; 14(5): 503 - 507. [Abstract] [Full Text] [PDF]

				P. Herijgers, S. Ozaki, E. Verbeken, A. Van Lommel, R. Racz, M. Zietkiewicz, B. Perek, and W. Flameng Calcification characteristics of porcine stentless valves in juvenile sheep Eur. J. Cardiothorac. Surg., February 1, 1999; 15(2): 134 - 142. [Abstract] [Full Text] [PDF]

				F. M.E. Hoekstra, M. Witvliet, C. Y. Knoop, C. Wassenaar, A. J.J.C. Bogers, W. Weimar, and F. H.J. Claas Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies Ann. Thorac. Surg., December 1, 1998; 66(6): 2022 - 2026. [Abstract] [Full Text] [PDF]

				P. Bertolini, G. B. Luciani, B. Vecchi, P. Pugliese, and A. Mazzucco Aortic valve replacement with the biocor PSB stentless xenograft Ann. Thorac. Surg., August 1, 1998; 66(2): 425 - 430. [Abstract] [Full Text] [PDF]

				G. B. Luciani, P. Bertolini, B. Vecchi, and A. Mazzucco Midterm results after aortic valve replacement with freehand stentless xenografts: a comparison of three prostheses J. Thorac. Cardiovasc. Surg., June 1, 1998; 115(6): 1287 - 1291. [Abstract] [Full Text] [PDF]

				B. Rajani, R. B. Mee, and N. B. Ratliff Evidence for rejection of homograft cardiac valves in infants J. Thorac. Cardiovasc. Surg., January 1, 1998; 115(1): 111 - 115. [Abstract] [Full Text] [PDF]

				F. W. Mohr, T. Walther, M. Baryalei, V. Falk, R. Autschbach, A. Scheidt, and H. Dalichau The Toronto SPV Bioprosthesis: One-Year Results in 100 Patients Ann. Thorac. Surg., July 1, 1995; 60(1): 171 - 175. [Abstract] [Full Text]

				M. Yacoub, N. R. H. Rasmi, T. M. Sundt, O. Lund, E. Boyland, R. Radley-Smith, A. Khaghani, and A. Mitchell Fourteen-year experience with homovital homografts for aortic valve replacement J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 186 - 194. [Abstract] [Full Text]

				M. G. Hazekamp, D. R. Koolbergen, J. Braun, H. Sugihara, C. J. Cornelisse, Y. A. Goffin, and H. A. Huysmans In situ hybridization: A new technique to determine the origin of fibroblasts in cryopreserved aortic homograft valve explants J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 248 - 257. [Abstract] [Full Text]

				B.G. Barratt-Boyes, G.W. Christie, and P.J. Raudkivi The stentless bioprosthesis: surgical challenges and implications for long-term durability Eur. J. Cardiothorac. Surg., January 1, 1992; 6(suppl_1): S39 - S43. [Abstract] [PDF]